Cleared Traditional

K033155 - BIOCENTREX CARDIAC PANEL

K033155 is an FDA 510(k) clearance for BIOCENTREX CARDIAC PANEL, manufactured by Biocentrex. The device is a Class 2 Chemistry device with product code MYT cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K033155 · Biocentrex · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2004
Decision
104d
Days
Class 2
Risk

K033155 is an FDA 510(k) clearance for the BIOCENTREX CARDIAC PANEL. Classified as Biosensor, Immunoassay, Cpk Or Isoenzymes (product code MYT), Class II - Special Controls.

Submitted by Biocentrex (Culver City, US). The FDA issued a Cleared decision on January 12, 2004 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Biocentrex devices

FDA 510(k) Submission Details - K033155

510(k) Number K033155 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2003
Decision Date January 12, 2004
Days to Decision 104 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
16d slower than avg
Panel avg: 88d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MYT Device Classification - Class 2, Special Controls

Product Code MYT Biosensor, Immunoassay, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.